Clinical trials
Phase 3 Homozygous Familial Hypercholesterolemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Regeneron Pharmaceuticals | 4 |
| Aegerion Pharmaceuticals, Inc. | 2 |
| Arrowhead Pharmaceuticals | 2 |
| Kastle Therapeutics, LLC | 2 |
| Amgen | 1 |
| LIB Therapeutics LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Homozygous Familial Hypercholesterolemia | 16 |
| Hyperlipoproteinemia Type II | 7 |
| Hypercholesterolemia | 6 |
| Dyslipidemias | 4 |
| Hyperlipidemias | 4 |
| Genetic Diseases, Inborn | 3 |
| Hyperlipoproteinemias | 3 |
| Lipid Metabolism Disorders | 3 |
| Lipid Metabolism, Inborn Errors | 3 |
| Metabolic Diseases | 3 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.